Evofem Biosciences, Inc.
EVFM
$0.0097
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 119.88% | -43.66% | -103.58% | 115.79% | -104.29% |
| Total Depreciation and Amortization | 1,808.33% | 1,368.18% | 729.73% | -95.95% | -95.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -368.54% | 217.65% | 101.43% | -182.07% | 5,352.38% |
| Change in Net Operating Assets | 95.25% | -157.74% | 201.94% | -100.10% | 197.31% |
| Cash from Operations | 355.28% | -1,316.47% | 80.58% | 23.63% | 102.49% |
| Capital Expenditure | -- | -- | -- | 100.00% | -366.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -307.14% | -- | -- | 100.00% | -366.67% |
| Total Debt Issued | -- | -100.00% | -100.00% | -20.28% | -- |
| Total Debt Repaid | -- | -73.38% | 73.80% | -- | -- |
| Issuance of Common Stock | -- | 4,210.34% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 627.35% | -53.32% | 91.62% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 237.61% | -88.82% | 113.27% | 100.33% | 103.36% |